Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$926,302
-$594,745 QoQ
Shares Held
2,558
-40.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,748
of 3,140 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gateway Wealth Partners, LLC holds $15,922,774 across 11 Drug Manufacturers - General names. AMGN ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,158 | $4,317,639 | |
| 2 | LLY |
ELI LILLY & Co
|
2,629 | $3,153,301 | |
| 3 | JNJ |
Johnson & Johnson
|
11,060 | $2,808,908 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,347 | $1,329,589 | |
| 5 | AZN |
Astrazeneca PLC
|
6,327 | $1,199,725 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,558 | $926,302 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,305 | $922,913 | |
| 8 | PFE |
Pfizer Inc
|
19,883 | $478,782 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $926,302 | 2,558 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,521,047 | 4,323 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $436,631 | 1,334 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $332,149 | 1,177 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $321,929 | 1,153 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $251,732 | 808 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||